|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Catastrophic cheerleadinginjuries显示文摘 | BODEN B P TACCHETTI R MUELLER F O | 2003 | AmJ Sports Med2003，，6： | 1 |
| 2 | Bortezomib with thalidomide plus dexamethasone compared with thalido- mide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem- cell transplantation in newly diagnosed multiple myelo- ma:a randomised phase 3 study 显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，9758： | 1 |
| 3 | Superior complete response rate and progression-free survival after autologous transplantation with up-front velcade-thalidomide-dexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma显示文摘 | Cavo M Tacchetti P Patriarca F | 2008 | Blood2008，112，11： | 1 |
| 4 | A phase III study of double autotransplantation incorporating bortezomib-thalidomide-dexamethasone (VTD) or thalidomide dexamethasone (TD) for multiple myeloma:superior clinical outcomes with VTD compared to TD显示文摘 | Cavo M Tacchetti P Patriarca F | 2009 | {H}Blood2009，，22： | 1 |
| 5 | Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double an- tologous stem-cell transplantation in newly diagnosed multiple myelo- ma: a randomised phase 3 study 显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，9758： | 1 |
| 6 | Multiple myeloma, venous thromboembolism,and treatment-related risk of thrombosis显示文摘 | Zamagni E Brioli A Tacchetti P | 2011 | Semin Thromb Hemost2011，37，3： | 1 |
| 7 | A PhaseⅢ study of double AutoTransPlantation incorporating bortezomib - thalidomide - dexam-ethasone(VTD) or thalidomide- dexameThasone (TD) for multiple myeloma:supefior clinical outcomes with VTD compared to TD显示文摘 | Cavo M Tacchetti P Patriarca F | 2009 | Blood( ASH Annu Meet Abstracts)2009，114，22： | 1 |
| 8 | N-CAM and N-cadherin expression during in vitro chondrogenesis显示文摘 | Tavella S Raffo P Tacchetti C | 1994 | Exp Cell Res1994，215，： | 1 |
| 9 | Multiple myeloma, venous thromboembolism,and treatment-related risk of thrombosis 显示文摘 | Zamagni E Brioli A Tacchetti P | 2011 | Semin Thmmb Hemost2011，37，3： | 1 |
| 10 | Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induetion therapy before, and consolida- tion therapy after, double autologous stem-eell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 显示文摘 | CAVO M TACCHETTI P PATRIARCA F | 2010 | The Lancet2010，376，9758： | 1 |
| 11 | Superior complete response rate and progression-free survival after autologous transplantation with up-front velcade-thalidomidedexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma显示文摘 | Cavo M Tacchetti P Patriarca F | 2008 | Blood2008，112，11： | 1 |
| 12 | Superior complete response rate and progression-free survial after autologous transplatation with up-front Velcade-thalidomide-dexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma显示文摘 | CAVO M TACCHETTI P PATRIARCA F | 2008 | Blood2008，112，： | 1 |
| 13 | Numb is an endoeytic protein显示文摘 | Santolini E Puri C Salcini A E Gagliani M C Pelicci P G Tacchetti C Di Fiore P P | | 0，，06： | 1 |
| 14 | Thalidomide-dexa- methasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed mul tiple myeloma and renal insuffieiency显示文摘 | Tosi P Zamagni E Tacchetti P | 2010 | Biol Blood Mar row Transplant2010，16，8： | 1 |
| 15 | N-CAM and N-cadherin expression during in vitro chondrogenesis显示文摘 | Tavel a S Raffo P Tacchetti C | | 0，，02： | 1 |
| 16 | Multiple myeloma, venous thromboembolism, and treatment-related risk of throm- bosis显示文摘 | Zamagni E Brioli A Tacchetti P | 2011 | Semin Thromb Hemost2011，37，3： | 1 |
| 17 | Bortezomib with thalido-mide plus dexamethasone compared with thalidomide plus dexa- methasone as induction therapy before, and consolidation therapy after, double autologous stem-ceU transplantation in newly diag- nosed multiple myeloma: a randomized phase 3 study显示文摘 | Cavo M Tacchetti P Patriarca K | 2010 | Lancet2010，376，9758： | 1 |
| 18 | Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before,and consolidation therapy after,double autologous stem-cell transplantation in newly diagnosed multiple myeloma:a randomised phase 3 study显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，： | 1 |
| 19 | Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before,and consolidation therapy after,double autologous transplantation in newly diagnosed multiple myeloma:a radomised phase 3 study显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，9758： | 1 |
| 20 | Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，9758： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员